Safety Reference
Warning
H341Suspected of causing genetic defects
H361Suspected of damaging fertility or the unborn child
H373May cause damage to organs through prolonged or repeated exposure
H400
Sourcing Lorlatinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Paritaprevir dihydrate
pharmaceutical raw material
Sourcing Lorlatinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Lorlatinib is an active pharmaceutical ingredient used in the manufacture of medications for non-small cell lung cancer. It acts as an inhibitor of anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (ROS1), making it a compound for targeted cancer research and pharmaceutical production.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
The international HS code for Lorlatinib (CAS 1454846-35-5) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile
IIXWYSCJSQVBQM-LLVKDONJSA-N
C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C